SciELO - Scientific Electronic Library Online

 
vol.155 suppl.1Supervivencia en cáncer de mama por subtipo mediante inmunohistoquímica: Un estudio retrospectivoEfecto de la amigdalotomía e hipotalamotomía unilateral en pacientes con agresividad refractaria índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Gaceta médica de México

versión On-line ISSN 2696-1288versión impresa ISSN 0016-3813

Resumen

DURAN-HERNANDEZ, Sofía et al. Tratamiento conservador de la osteoartrosis de cadera con toxina botulínica tipo A. Gac. Méd. Méx [online]. 2019, vol.155, suppl.1, pp.56-61.  Epub 01-Jul-2021. ISSN 2696-1288.  https://doi.org/10.24875/gmm.19005151.

Introduction:

Osteoarthritis (OA) of the hip is a low-grade inflammatory disease of multiple etiology that has a limited conservative management and insufficiently explored. The application of botulinum toxin type A (BoNT-A) produces in the applied muscle a temporary, delimitable and reversible flaccid paralysis, which applicated in a strategic way achives to reduce mechanical stress and pain.

Objective:

To evaluate the effect on pain perception, functionality and rigidity and changes in flexibility, internal and external rotation, before and 90 days after the application of BoNT-A.

Methods:

Clinical, experimental, longitudinal, open study, with a total of 35 patients and 45 hips treated. BoNT-A of 500 U was applied in iliac, adductor brevis and longus muscles.

Results:

The Wilcoxon test was used to compare the evaluation scores on days 0-90, observing the decrease in referred pain (p < 0.0001), rigidity (p < 0.002), improved perceived function (p < 0.001) and mobility arcs: flexion, internal and external rotation (p < 0.0001).

Conclusions:

The treatment with BoNT-A provides a conservative and safe option for the management of symptoms and physical restraint caused by hip OA.

Palabras llave : Osteoarthritis; Botulinum toxin; Chronic pain.

        · resumen en Español     · texto en Español